Pharmaceutical & Biotechnology
Vasomune Therapeutics
About this employer
Vasomune Therapeutics is a private biotechnology company in Toronto, ON, with an office in Raleigh, North Carolina, developing medicines to block vascular leak. Its lead candidate, AV-001 (pegevongitide), activates the Tie2 receptor to stabilize blood vessels and is in clinical development for pneumonia and acute respiratory distress syndrome, with FDA Fast Track designation.